Search results for "inflammatory"

showing 10 items of 1845 documents

Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multic…

2011

Granulocyte colony-stimulating factor (G-CSF) induces a transient mobilization of hematopoietic progenitor cells from bone marrow to peripheral blood. Our aim was to evaluate safety of repeated courses of G-CSF in patients with amyotrophic lateral sclerosis (ALS), assessing disease progression and changes in chemokine and cytokine levels in serum and cerebrospinal fluid (CSF). Twenty-four ALS patients entered an open-label, multicenter trial in which four courses of G-CSF and mannitol were administered at 3-month intervals. Levels of G-CSF were increased after treatment in the serum and CSF. Few and transitory adverse events were observed. No significant reduction of the mean monthly decrea…

medicine.medical_specialtyPhysiologybusiness.industryMonocyteGranulocytemedicine.diseaseGastroenterologyGranulocyte colony-stimulating factorProinflammatory cytokineCellular and Molecular Neurosciencemedicine.anatomical_structureCerebrospinal fluidPhysiology (medical)Internal medicineMulticenter trialImmunologymedicineNeurology (clinical)Bone marrowAmyotrophic lateral sclerosisbusinessMuscle & Nerve
researchProduct

Anxiety, depression, chronic inflammation and aortic stiffness in Crohn's disease: the brain--gut--vascular axis.

2020

Background Patients with Crohn's disease have an increased aortic stiffness, a known cardiovascular risk factor. Anxiety, a key factor of the brain--gut axis in patients with Crohn's disease, is implicated in the pathogenesis and progression of the disease, and is linked with aortic stiffening in other clinical settings. Objectives Considering that depression is frequently linked to anxiety in Crohn's disease, we performed a mediation analysis to reveal the potential link between anxiety, depression and aortic stiffness in these patients. Methods Multicentre observational cross-sectional study of 86 consecutive patients with Crohn's disease and 86 matched control individuals. The connection…

medicine.medical_specialtyPhysiologypulse wave velocityDisease030204 cardiovascular system & hematologyAnxietyInflammatory bowel diseaseInflammatory bowel disease03 medical and health sciences0302 clinical medicineVascular StiffnessCrohn DiseaseInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineRisk factorPulse wave velocityDepression (differential diagnoses)Aortaarterial stiffness inflammation inflammatory bowel disease pulse wave velocityInflammationCrohn's diseasebusiness.industryDepressionPulse wave velocity.medicine.diseaseGastrointestinal MicrobiomeArterial stiffnearterial stiffnessCross-Sectional StudiesArterial stiffnessCardiologyAnxietymedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of hypertension
researchProduct

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

2020

The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohort, from a multicenter cohort from 21st of February to 30th of June, 2020. Ninety-seven patients with IBD (43 UC, 53 CD, one unclassified IBD) and concomitant COVID-19 over a total of 23,879 patients with IBD were enrolled in the study. The cumulative incidence of SARS-CoV-2 infection in patients with IBD vs. the general population was 0.406% and 0.402% cases, respectively. Twenty-three patients (…

medicine.medical_specialtyPopulationlcsh:MedicineInflammatory bowel diseaseArticledrugslaw.invention03 medical and health sciences0302 clinical medicinelawinflammatory bowel diseaseInternal medicinemedicineCumulative incidenceeducationeducation.field_of_studyimmunosuppressionbusiness.industryIncidence (epidemiology)lcsh:RCOVID-19General Medicinemedicine.diseaseIntensive care unitdigestive system diseasesPneumonia030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologybusinessCohort studyJournal of Clinical Medicine
researchProduct

Recent advances and disputes about curcumin in retinal diseases

2021

Abstract Curcumin belongs to the group of so-called phytocompounds, biologically active molecules produced by plants exerting a beneficial effect on health. Curcumin shows a wide spectrum of different properties, being an anti-inflammatory, antioxidant, antimicrobial and antimutagenic molecule. The purpose of the review is to examine what literature reported on the characteristics of curcumin, particularly, on the beneficial and controversial aspects of this molecule, aiming for a better therapeutic management of retinal diseases. The retina is a constant target of oxidative stress, this tissue being characterized by cells rich in mitochondria and by vessels and being, obviously, continuous…

medicine.medical_specialtyProliferative vitreoretinopathyantioxidant proprietiesReviewexosomesPharmacologymedicine.disease_causeRetinal ganglionanti-inflammatory proprieties; antioxidant proprieties; exosomes; miRNA; nanosphere; natural compounds03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOphthalmologymedicinenatural compoundsanti-inflammatory proprietiesmiRNARetinabusiness.industryRetinalDiabetic retinopathyMacular degenerationmedicine.diseasenanosphereOphthalmologymedicine.anatomical_structurechemistry030221 ophthalmology & optometryCurcuminbusiness030217 neurology & neurosurgeryOxidative stress
researchProduct

Primary thromboembolic prevention in multiple myeloma patients: An exploratory meta-analysis on aspirin use

2018

Background: Multiple myeloma (MM) is a common hematological disorder, often complicated by venous thromboembolism, especially during treatment with immunomodulatory drugs. Acetylsalicylic acid (ASA) has been extensively used as thromboprophylaxis but its rationale is unclear and the efficacy versus low-molecular weight heparins (LMWH) is still matter of debate. European and American guidelines suggest different approaches and the optimal antithrombotic strategy is yet to be established. Methods: We conducted an exploratory metanalysis and a systematic review on studies comparing ASA versus other interventions for thromboprophylaxis (no intervention or LMWH) in patients with MM. Results: Ten…

medicine.medical_specialtyPsychological intervention030204 cardiovascular system & hematologyLower risknot knownlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineAntithromboticHumansMedicineMultiple myelomaRetrospective StudiesAspirinAspirinbusiness.industryAnti-Inflammatory Agents Non-SteroidalRetrospective cohort studyVenous ThromboembolismHematologymedicine.diseaseSurgery030220 oncology & carcinogenesisMeta-analysisMultiple Myelomabusinessmedicine.drugSeminars in Hematology
researchProduct

Gastrointestinal perforation: ultrasonographic diagnosis.

2013

Abstract Gastrointestinal tract perforations can occur for various causes such as peptic ulcer, inflammatory disease, blunt or penetrating trauma, iatrogenic factors, foreign body or a neoplasm that require an early recognition and, often, a surgical treatment. Ultrasonography could be useful as an initial diagnostic test to determine, in various cases the presence and, sometimes, the cause of the pneumoperitoneum. The main sonographic sign of perforation is free intraperitoneal air, resulting in an increased echogenicity of a peritoneal stripe associated with multiple reflection artifacts and characteristic comet-tail appearance. It is best detected using linear probes in the right upper q…

medicine.medical_specialtyRadiological and Ultrasound TechnologyIleusultrasoundbusiness.industryResearchPerforation (oil well)gastrointestinal disease (diagnosis)inflammatorymedicine.diseaseAbdominal wallmedicine.anatomical_structurePneumoperitoneumGastrointestinal perforationmedicineRadiologygastrointestinal disease (diagnosis); ultrasound; inflammatoryForeign bodymedicine.symptombusinessPenetrating traumaSubcutaneous emphysema
researchProduct

SAT0571 OPTICAL SPECTRAL TRANSMISSION TO ASSESS THERAPY RESPONSE IN PATIENTS WITH ARTHRITIS: A COMPARATIVE STUDY WITH CLINICAL, LABORATORY AND ULTRAS…

2020

Background:Valid assessment of disease activity leads to outcome improvement in patients with rheumatoid arthritis (RA) (1). Optical spectral transmission (OST) is a modern diagnostic tool able to assess the blood-specific absorption of light transmitted through a tissue, promising quantification of inflammation in the finger and wrist joints of RA patients (commercial device: HandScan - Hemics, The Netherlands) (2).Objectives:To our knowledge, there are no data regarding the diagnostic value of OST in the evaluation of inflammatory activity changes during arthitis follow up.Thus, aims of this study were to examine the ability of OST to detect response to anti-inflammatory therapy in patien…

medicine.medical_specialtyReceiver operating characteristicbusiness.industryInflammatory arthritisImmunologyArthritisDiseaseWristmedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyGoutmedicine.anatomical_structureRheumatologyInternal medicineRheumatoid arthritismedicineImmunology and AllergyIn patientbusinessAnnals of the Rheumatic Diseases
researchProduct

ENTERAL NUTRITION SUPPORT TO TREAT MALNUTRITION IN INFLAMMATORY BOWEL DISEASE

2015

Malnutrition is a common consequence of inflammatory bowel disease (IBD). Diet has an important role in the management of IBD, as it prevents and corrects malnutrition. It is well known that diet may be implicated in the aethiology of IBD and that it plays a central role in the pathogenesis of gastrointestinal tract disease. Often oral nutrition alone is not sufficient in the pathogenesis of gastrointestinal tract disease. Often oral nutrition alone is not sufficient in the management of IBD patients, especially in children or elederly, and must be combined with oral supplementation or replaced with tube enteral nutrition. In this review, we describe several different approaches to enteral …

medicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaInflammatory Bowel Diseases IBD enteral feeding mulnutrition dysbiosis dismicrobism home enteral nutritionNutritional Statuslcsh:TX341-641ReviewDiseaseClinical nutritionInflammatory bowel diseaseEnteral administrationEnteral Nutritioninflammatory bowel diseasemedicineHumansDisease management (health)tube feedingIntensive care medicineSettore MED/12 - GastroenterologiaNutrition and Dieteticsbusiness.industryMalnutritionDisease ManagementInflammatory Bowel Diseasesmedicine.diseasedigestive system diseasesMalnutritionSettore MED/18 - Chirurgia GeneraleParenteral nutritionhome enteral nutritionEtiologyenteral feedingnutrients supplementationbusinesslcsh:Nutrition. Foods and food supplyFood Science
researchProduct

Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?

2010

5-Amino-salacylic acid (5-ASA) is up to now the treatment of choice in the induction and maintenance of remission of mild-to-moderate ulcerative colitis (UC). Sulfasalazine, despite similar efficacy, is hampered by more side effects, but in presence of peripheral arthopaties it remains the treatment of choice. The new delayed release MMX formulation seems to be promising in reducing compliance problems, but further studies are warranted to show the superiority of new MMX formulation compared with the older formulations of 5-ASA. Some trials evaluated also the efficacy and safety of once-daily dosing of older 5-ASA formulations in maintenance of remission, finding a greater adherence to ther…

medicine.medical_specialtySettore MED/09 - Medicina InternaClinical BiochemistryPharmacologyPlaceboSulfasalazineInternal medicineDrug DiscoverymedicineHumansDosingColitisMesalamine5-ASA Treatment Choice Ulcerative ColitisPharmacologyClinical Trials as Topicbusiness.industryAnti-Inflammatory Agents Non-Steroidalmedicine.diseaseUlcerative colitisTacrolimusRegimenMolecular MedicineColitis UlcerativeRosiglitazonebusinessmedicine.drugCurrent Drug Targets
researchProduct

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

2014

Many placebo controlled trials and meta-analyses evaluated the efficacy of different drugs for the treatment of inflammatory bowel disease (IBD), including immunosuppressants and biologics. Their use is indicated in moderate to severe disease in non responders to corticosteroids and in steroid-dependent patients, as induction and maintainance treatment. Infliximab, as well as cyclosporine, is considered a second line therapy in the case of severe ulcerative colitis, or non-responders to intravenous corticosteroids. An adequate dosage and duration of therapy with thiopurines should be reached before evaluating their efficacy. Methotrexate is a valid option in patients with Crohn’s disease bu…

medicine.medical_specialtySettore MED/09 - Medicina InternaCombination therapyInflammatory bowel diseaseGastroenterologyimmunosuppresantbiologicsinflammatory bowel diseaseCrohn DiseaseGastrointestinal AgentsRisk FactorsInternal medicinemedicineimmunomodulators.optimization. treatmentHumansTopic HighlightBiological ProductsGastrointestinal agentCrohn's diseaseThiopurine methyltransferasebiologybusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisTacrolimusInfliximabSurgeryTreatment Outcomebiology.proteinColitis UlcerativeDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct